Medical marijuana helps women with endometriosis achieve long-term improvements in their symptoms while also reducing the use of opioids, according to a new study.
Using cannabis-based medicinal products (CBMPs) “was associated with sustained improvements in pain, health-related quality of life, sleep, and anxiety at 24 months,” the research found. Cannabis was also “well tolerated” by most patients, demonstrating a “favourable” adverse event profile.
Additionally, the study showed a reduction in prescribed opioids at 18 and 24 months—”including a clinically significant reduction in 26.1% of participants at 24 months,” the researchers wrote.
The study involved 101 biological women diagnosed with endometriosis, a chronic condition that involves tissue similar to the lining of the womb growing outside of it. The disease can cause pain and scarring, and sometimes leads to difficultly getting pregnant.
“Across 24 months, improvements were observed in measures of pain severity, its impact on health-related quality of life (HRQoL), sleep, and anxiety.”
All participants had been signed up with the UK Medical Cannabis Registry for at least two years prior to joining the study. Data was collected at the launch of the research and again 1, 3, 6, 12, 18 and 24 months later using a series of patient self-report surveys.
“Mean prescribed [oral
Read full article on Marijuana Moment
